FDA adds precautionary warning for Tamiflu

11/14/2006 | Washington Post (tiered subscription model), The

The agency announced an updated label for the flu drug, saying those taking Tamiflu should be closely monitored for abnormal behavior. The FDA says it has received more than 100 reports of injury and delirium associated with children taking the Roche Holding drug, most of them coming from Japan. A Roche spokesman says there was no evidence the drug caused the side effects.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health